The authors show that this model, which includes both sex hormone and growth hormone effects, allows a detailed insight into sex-dependent liver pathologies and they use the model to identify the most important sex-dependent pathways involved in non-alcoholic fatty liver disease. This evidence concerns the gene GH1 and metabolic dysfunction-associated steatotic liver disease.